General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
PRESS RELEASE
| FOR
IMMEDIATE RELEASE: March 17 , 2008 |
Contact: Stacy Fiedler at 703-294-6003 or press@treatmentadvocacycenter.org |
Severe Shortage of Psychiatric Beds Sounds National Alarm Bell
Report finds US deficit of nearly 100,000 inpatient beds; result is increased homelessness, emergency room overcrowding, and use of jails and prisons as de-facto psychiatric hospitals
Arlington, Va. – A new report released today by the Treatment Advocacy Center reveals that for every 20 public psychiatric beds that existed in the US in 1955, only 1 such bed existed in 2005.
According to data cited in The Shortage of Hospital Beds for Mentally Ill Persons, in 1955 there were 340 public psychiatric beds available per 100,000 U.S. citizens. By 2005, the number plummeted to a staggering 17 beds per 100,000 persons. Mississippi was found to have the most beds available in 2005 (49.7 per 100,000 people), while Nevada (5.1) and Arizona (5.9) had the least. For the complete report, state-by-state ranking of beds lost, and list of recommendations visit: http://www.treatmentadvocacycenter.org/Reportbedshortage.htm
“The results of this report are dire and the failure to provide care for the most seriously mentally ill individuals is disgraceful,” said lead author, Dr. E. Fuller Torrey, president of the Treatment Advocacy Center. “Our communities are paying a high price for our failure to treat those with severe and persistent mental illness, and those not receiving treatment are suffering severely. In addition, untreated persons with severe mental illnesses have become major problems in our homeless shelters, jails, public parks, public libraries, and emergency rooms and are responsible for at least 5 percent of all homicides.”
To determine a minimum number of beds needed, a consensus of experts involved in the study looked at specific criteria such as number of individuals who need hospitalization, length of hospital stay, and current state and federal financing structures. They also were asked to assume that effective community based services and assisted outpatient treatment (AOT) programs are available in all 50 states. Using these criteria, the panel concluded that 50 public psychiatric beds per 100,000 individuals is the absolute minimum number required to meet current needs. Eight states still don’t have AOT and many states are in need of additional community mental health services, making 50 public psychiatric beds per 100,000 people a minimum requirement.
“This report confirms what many in the mental health field already know – too many people with severe mental illnesses aren’t getting treatment,” said report co-author, Dr. Jeffery Geller. “Someone with schizophrenia who is having a psychotic break should not be told they can’t get treatment in their own community, nor should they be told to wait and wait and wait for treatment. We are talking about people in need of immediate care.”
State Rankings
The states with the fewest beds in 2005 were: Nevada (5.1 beds per 100,000 people), Arizona (5.9), Arkansas (6.7), Iowa (8.1), Vermont (8.9) and Michigan (9.9). The states with the most beds available were South Dakota (40.3) and Mississippi (49.7). In 32 states the bed shortage was critical or severe, 42 states had less than half the minimum number of beds needed, and six states had less than 20 percent of the minimum beds needed to provide adequate care.
"One small silver lining in this otherwise alarming study is that Mississippi meets the 50 bed standard,” said study co-author and Treatment Advocacy Center executive director, Kurt Entsminger. “If the state which ranks 49 in per capita income can achieve the 50 bed standard, then states with greater wealth have no excuse for their failure to do so."
Consequences of Bed Shortage
Because there are so few beds available, individuals with severe psychiatric disorders who need to be hospitalized are often unable to get admitted. Those who are admitted are often discharged prematurely and without a treatment plan. The consequences of the radical reduction in psychiatric hospital beds are evidenced in the following areas:
Recommendations
The present severe shortage of public psychiatric beds should not be tolerated and can be ameliorated in the following ways:
“There’s no question we need more public psychiatric beds, but the consequences of the severe bed shortage can also be improved with wide-spread utilization of PACT and AOT,” said Dr. Torrey.
“Both of these outpatient treatment options are proven successful ways to treat people with severe mental illnesses in the community. AOT has proven to reduce psychiatric hospitalizations by more than 70 percent.”
The Treatment Advocacy Center (www.treatmentadvocacycenter.org) is a national nonprofit organization dedicated to eliminating barriers to the timely and effective treatment of severe mental illnesses. TAC promotes laws, policies, and practices for the delivery of psychiatric care and supports the development of innovative treatments for and research into the causes of severe and persistent psychiatric illnesses, such as schizophrenia and bipolar disorder.
We take no money from pharmaceutical companies. The American Psychiatric Association awarded TAC its 2006 presidential commendation for "sustained extraordinary advocacy on behalf of the most vulnerable mentally ill patients.”
ADDITIONAL INFORMATION
press room
general
resources | legal resources | medical
resources | briefing papers | state activity
hospital closures | preventable
tragedies | press room | search
| home
The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. § 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. § 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products. Treatment Advocacy Center (TAC), 200 N. Glebe Road, Suite 730, Arlington, VA 22203 703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website) info@treatmentadvocacycenter.org (general email) | press@treatmentadvocacycenter.org (press contact) webmaster@treatmentadvocacycenter.org (webmaster) |